Medivolve Announces Q3 2021 Results – Reaches Record Levels of Revenue
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
[vc_row type=”vc_default” css=”.vc_custom_1482746133348{padding-bottom: 100px !important;}”][vc_column width=”1/3″][vc_column_text css=”.vc_custom_1482745392443{padding-bottom: 30px !important;}”]
[/vc_column_text][/vc_column][vc_column width=”2/3″]
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
Medivolve Inc. is pleased to announce that it has closed the previously announced private placement of an aggregate of 7,142,857 units at a price per Unit of $0.07 for aggregate gross proceeds to the Company of $500,000.
The Company plans to use the net proceeds from the Offering to expand its operating business, enhance regulatory capital, marketing, and for general corporate purposes.
[/vc_column_text][/vc_column][vc_column width=”2/3″]
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
Medivolve Inc. is pleased to announce that it has closed the previously announced private placement of an aggregate of 7,142,857 units at a price per Unit of $0.07 for aggregate gross proceeds to the Company of $500,000.
The Company plans to use the net proceeds from the Offering to expand its operating business, enhance regulatory capital, marketing, and for general corporate purposes.
[/vc_column_text][/vc_column][vc_column width=”2/3″]
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
Medivolve Inc. is pleased to announce that it has closed the previously announced private placement of an aggregate of 7,142,857 units at a price per Unit of $0.07 for aggregate gross proceeds to the Company of $500,000.
The Company plans to use the net proceeds from the Offering to expand its operating business, enhance regulatory capital, marketing, and for general corporate purposes.
[/vc_column_text][/vc_column][vc_column width=”2/3″]
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
Medivolve Inc. is pleased to announce that it has closed the previously announced private placement of an aggregate of 7,142,857 units at a price per Unit of $0.07 for aggregate gross proceeds to the Company of $500,000.
The Company plans to use the net proceeds from the Offering to expand its operating business, enhance regulatory capital, marketing, and for general corporate purposes.
[/vc_column_text][/vc_column][vc_column width=”2/3″]
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
Medivolve Inc. is pleased to announce that it has closed the previously announced private placement of an aggregate of 7,142,857 units at a price per Unit of $0.07 for aggregate gross proceeds to the Company of $500,000.
The Company plans to use the net proceeds from the Offering to expand its operating business, enhance regulatory capital, marketing, and for general corporate purposes.